{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:54:39Z","timestamp":1782316479718,"version":"3.54.5"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T00:00:00Z","timestamp":1775347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostate International"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.prnil.2026.04.002","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T01:11:22Z","timestamp":1775783482000},"page":"198-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Omitting biopsy in Prostate Imaging Reporting and Data System 3? The role of Stockholm3 and prostate-specific antigen density findings from a prospective Swiss non-referral cohort"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4122-8249","authenticated-orcid":false,"given":"Nicolas","family":"Arnold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Mudlagk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Minder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Cornelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Di Bona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livio","family":"Mordasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Giudici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prnil.2026.04.002_bib1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate Cancer\u20142024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.prnil.2026.04.002_bib2","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.euf.2019.06.014","article-title":"Prostate imaging reporting and data system 3 category cases at multiparametric magnetic resonance for prostate cancer: a systematic review and meta-analysis","volume":"6","author":"Maggi","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.prnil.2026.04.002_bib3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/jmri.26882","article-title":"Interobserver agreement of PI-RADS v. 2 lexicon among radiologists with different levels of experience","volume":"51","author":"Mussi","year":"2020","journal-title":"J Magn Reson Imag"},{"key":"10.1016\/j.prnil.2026.04.002_bib4","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.jacr.2021.02.032","article-title":"Prostate imaging and data reporting system version 2 as a radiology performance metric: an analysis of 18 abdominal radiologists","volume":"18","author":"Davenport","year":"2021","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.prnil.2026.04.002_bib5","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1007\/s00261-019-01919-2","article-title":"False positives in PIRADS (V2) 3, 4, and 5 lesions: relationship with reader experience and zonal location","volume":"44","author":"Stolk","year":"2019","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.prnil.2026.04.002_bib6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/pros.24832","article-title":"PI-RADS in predicting csPCa: a comparison between academic and nonacademic centers","volume":"85","author":"Orsini","year":"2025","journal-title":"Prostate"},{"key":"10.1016\/j.prnil.2026.04.002_bib7","doi-asserted-by":"crossref","first-page":"396.e1","DOI":"10.1016\/j.urolonc.2024.10.002","article-title":"Inter-reader reliability and diagnostic accuracy of PI-RADS scoring between academic and community care networks: how wide is the gap?","volume":"43","author":"Smani","year":"2025","journal-title":"Urol Oncol"},{"key":"10.1016\/j.prnil.2026.04.002_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4111\/icu.20250208","article-title":"Enhancement of inter-\/intra-reader agreement using the prostate imaging reporting and data system version 2.1 for prostate cancer detection in magnetic resonance imaging\/transrectal ultrasound software fusion prostate biopsy","volume":"66","author":"Song","year":"2025","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.prnil.2026.04.002_bib9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.prnil.2024.03.005","article-title":"Negative magnetic resonance imaging cannot be used to omit an initial prostate biopsy - an ambispective study","volume":"12","author":"Arulraj","year":"2024","journal-title":"Prostate Int"},{"key":"10.1016\/j.prnil.2026.04.002_bib10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.prnil.2024.04.002","article-title":"Utility of transperineal template-guided mapping prostate biopsy in biopsy-na\u00efve men with PI-RADS 1-2 on multiparametric magnetic resonance imaging","volume":"12","author":"Lee","year":"2024","journal-title":"Prostate Int"},{"key":"10.1016\/j.prnil.2026.04.002_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/bju.15277","article-title":"Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation","volume":"127","author":"Schoots","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.prnil.2026.04.002_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.euf.2022.10.002","article-title":"Prostate-specific antigen density cutoff of 0.15 ng\/ml\/cc to propose prostate biopsies to patients with negative magnetic resonance imaging: Efficient threshold or legacy of the past?","volume":"9","author":"Pellegrino","year":"2023","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.prnil.2026.04.002_bib13","series-title":"EAU guidelines edn presented at the EAU annual congress Madrid","article-title":"EAU - EANM - ESTRO - ESUR - ISUP - SIOG guidelines on prostate cancer 2025","author":"Cornford","year":"2025"},{"key":"10.1016\/j.prnil.2026.04.002_bib14","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/S1470-2045(15)00361-7","article-title":"Prostate cancer screening in men aged 50\u201369 years (STHLM3): a prospective population-based diagnostic study","volume":"16","author":"Gr\u00f6nberg","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prnil.2026.04.002_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41391-018-0082-5","article-title":"The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort","volume":"22","author":"M\u00f6ller","year":"2019","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.prnil.2026.04.002_bib16","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.euf.2023.09.016","article-title":"Prospective multicenter validation of the Stockholm3 test in a central European cohort","volume":"10","author":"Elyan","year":"2024","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.prnil.2026.04.002_bib17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.euo.2018.09.008","article-title":"A unified prostate cancer risk prediction model combining the Stockholm3 test and magnetic resonance imaging","volume":"2","author":"Palsdottir","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.prnil.2026.04.002_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41391-020-00297-x","article-title":"Biomarker discrimination and calibration with MRI-targeted biopsies: an analysis with the Stockholm3 test","volume":"24","author":"Vigneswaran","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.prnil.2026.04.002_bib19","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S1470-2045(21)00348-X","article-title":"Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial","volume":"22","author":"Nordstr\u00f6m","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prnil.2026.04.002_bib20","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.eururo.2018.06.022","article-title":"Prostate cancer diagnostics using a combination of the Stockholm3 blood test and multiparametric magnetic resonance imaging","volume":"74","author":"Gr\u00f6nberg","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.prnil.2026.04.002_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103191","article-title":"Evaluating the performance of existing tools to predict clinically significant prostate cancer in men with indeterminate lesions on biparametric MRI and development of a novel multiplex model: a prospective cohort study","volume":"82","author":"Abbadi","year":"2025","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.prnil.2026.04.002_bib22","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.prnil.2026.04.002_bib23","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.eururo.2016.07.041","article-title":"Comparing three different techniques for magnetic resonance imaging-targeted prostate biopsies: a systematic review of In-bore versus magnetic resonance imaging-transrectal ultrasound fusion versus cognitive registration. Is there a preferred technique?","volume":"71","author":"Wegelin","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.prnil.2026.04.002_bib24","doi-asserted-by":"crossref","first-page":"490.e1","DOI":"10.1016\/j.urolonc.2022.08.003","article-title":"Utility of PSA density in patients with PI-RADS 3 lesions across a large multi-institutional collaborative","volume":"40","author":"Drevik","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.prnil.2026.04.002_bib25","doi-asserted-by":"crossref","first-page":"354.e11","DOI":"10.1016\/j.urolonc.2023.05.005","article-title":"Optimal PSA density threshold and predictive factors for the detection of clinically significant prostate cancer in patient with a PI-RADS 3 lesion on MRI","volume":"41","author":"Nguyen","year":"2023","journal-title":"Urol Oncol"},{"key":"10.1016\/j.prnil.2026.04.002_bib26","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1002\/cncr.34355","article-title":"Multi-institutional analysis of clinical and imaging risk factors for detecting clinically significant prostate cancer in men with <scp>PI-RADS<\/scp> 3 lesions","volume":"128","author":"Fang","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.prnil.2026.04.002_bib27","article-title":"Evaluating PI-RADS lesions and clinically significant prostate cancer in black and Asian men: a PREVENT randomized clinical trial secondary analysis","author":"Driscoll","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.prnil.2026.04.002_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/02813432.2020.1802139","article-title":"Effects of replacing PSA with Stockholm3 for diagnosis of clinically significant prostate cancer in a healthcare system - the stavanger experience","volume":"38","author":"Viste","year":"2020","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.prnil.2026.04.002_bib29","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.eururo.2025.05.020","article-title":"Prostate cancer detection in younger men: a comparative analysis of systematic and magnetic resonance imaging-targeted biopsy in the PROBASE trial","volume":"88","author":"Al-Monajjed","year":"2025","journal-title":"Eur Urol"}],"container-title":["Prostate International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2287888226000292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2287888226000292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:28:19Z","timestamp":1782314899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2287888226000292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2287888226000292"],"URL":"https:\/\/doi.org\/10.1016\/j.prnil.2026.04.002","relation":{},"ISSN":["2287-8882"],"issn-type":[{"value":"2287-8882","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omitting biopsy in Prostate Imaging Reporting and Data System 3? The role of Stockholm3 and prostate-specific antigen density findings from a prospective Swiss non-referral cohort","name":"articletitle","label":"Article Title"},{"value":"Prostate International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prnil.2026.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Asian Pacific Prostate Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}